brl 42810 has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Excerpt | Relevance | Reference |
---|---|---|
"We described two chronic hepatitis B carriers (both hepatitis B e antigen negative), who cleared HBsAg after allogeneic bone marrow transplantation." | 1.30 | Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer. ( Au, WY; Lau, GK; Liang, R; Wu, PC; Yuen, ST, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lau, GK | 1 |
Yuen, ST | 1 |
Au, WY | 1 |
Wu, PC | 1 |
Liang, R | 1 |
1 other study available for brl 42810 and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Famciclovir; Hepati | 1999 |